ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-3.57%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$259M
AUM Growth
+$259M
(+2.1%)
Cap. Flow
-$465M
Cap. Flow
% of AUM
-179.55%
Top 10 Holdings %
Top 10 Hldgs %
60.28%
Holding
68
New
17
Increased
13
Reduced
17
Closed
19
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$13.9M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$13.8M |
| 3 |
HCA Healthcare
HCA
|
$12.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
$10.4M |
| 5 |
Charles River Laboratories
CRL
|
$9.93M |
Top Sells
| 1 |
Takeda Pharmaceutical
TAK
|
$14.5M |
| 2 |
iRhythm Technologies
IRTC
|
$8.18M |
| 3 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$7.03M |
| 4 |
Encompass Health
EHC
|
$6.52M |
| 5 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
$6.48M |
Sector Composition
| 1 | Healthcare | 82.5% |
| 2 | Industrials | 8.2% |
| 3 | Technology | 0.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Inspire Medical Systems
INSP
$2.53B
| $1.88M | 0.67% |
+30,805
| New | +$1.88M |
|
|
SDC
27
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $1.85M | 0.66% |
+133,388
| New | +$1.85M |
|
28
Standard BioTools
LAB
$493M
| $1.83M | 0.66% |
+395,701
| New | +$1.83M |
|
|
29
Takeda Pharmaceutical
TAK
$47.8B
| $1.59M | 0.57% |
92,273
-840,694
| -90% | -$14.5M |
|
30
Iovance Biotherapeutics
IOVA
$800M
| $1.57M | 0.56% |
86,069
-87,169
| -50% | -$1.59M |
|
|
IIN
31
DELISTED
IntriCon Corporation
IIN
| $1.43M | 0.51% |
73,543
-316,252
| -81% | -$6.15M |
|
32
AstraZeneca
AZN
$255B
| $1.38M | 0.5% |
31,031
-93,828
| -75% | -$4.18M |
|
33
CONMED
CNMD
$1.64B
| $1.26M | 0.45% |
+13,112
| New | +$1.26M |
|
34
Liquidia Corp
LQDA
$2.52B
| $1.13M | 0.41% |
317,993
-150,988
| -32% | -$537K |
|
35
Humana
HUM
$37.5B
| $997K | 0.36% |
3,899
-23,898
| -86% | -$6.11M |
|
|
PETQ
36
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $936K | 0.34% |
+34,354
| New | +$936K |
|
37
AtriCure
ATRC
$1.73B
| $858K | 0.31% |
34,391
-184,647
| -84% | -$4.61M |
|
|
38
Encompass Health
EHC
$12.5B
| $753K | 0.27% |
14,948
-129,357
| -90% | -$6.52M |
|
|
AXNX
39
DELISTED
Axonics, Inc. Common Stock
AXNX
| $747K | 0.27% |
+27,759
| New | +$747K |
|
40
Acadia Healthcare
ACHC
$2.15B
| $743K | 0.27% |
+23,918
| New | +$743K |
|
41
Prothena Corp
PRTA
$452M
| $677K | 0.24% |
+86,407
| New | +$677K |
|
|
XENT
42
DELISTED
Intersect ENT, Inc
XENT
| $643K | 0.23% |
37,815
-232,746
| -86% | -$3.96M |
|
|
GNCA
43
DELISTED
Genocea Biosciences, Inc.
GNCA
| $546K | 0.2% |
188,128
-101,586
| -35% | -$295K |
|
44
Apellis Pharmaceuticals
APLS
$3.51B
| $537K | 0.19% |
+22,281
| New | +$537K |
|
|
NTGN
45
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $332K | 0.12% |
193,052
-272,598
| -59% | -$469K |
|
46
Actinium Pharmaceuticals
ATNM
$53.3M
| $311K | 0.11% |
45,139
-37,573
| -45% | -$259K |
|
47
Adverum Biotechnologies
ADVM
$68.2M
| – | – |
-3,187
| Closed | -$379K |
|
48
Align Technology
ALGN
$9.59B
| – | – |
-1,962
| Closed | -$537K |
|
49
DaVita
DVA
$9.72B
| – | – |
-32,566
| Closed | -$1.83M |
|
|
CBIO
50
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| – | – |
-423
| Closed | -$504K |
|